Dr. Barry Sheane is a Consultant Rheumatologist at the Mater Private Hospital, Dublin.
Education & Experience
Dr. Sheane is a medical graduate of Trinity College, Dublin. He completed a research fellowship at St James’s Hospital/Trinity College between 2007 and 2010, undertaking an MD thesis examining novel risk factors and correlates for cardiovascular disease in inflammatory arthritis, culminating in a number of presentations at national and international scientific meetings. During this time, he established an Early Arthritis Clinic to eliminate delays in assessing and treating patients with potentially deforming and disabling forms of arthritis. He also pioneered the Smoking Cessation Incentives Programme, an education-based patient-centred course involving a multidisciplinary team to encourage and assist patients with Rheumatoid Arthritis to quit smoking.
Dr. Sheane was awarded research fellowships at St James’ Hospital/ Trinity College Dublin and Toronto Western Hospital, Canada, before returning to Dublin to complete his higher speciality training in Rheumatology.
In 2012, he was awarded the Bresnihan-Molloy International Education Fellowship, allowing him to begin a clinical research fellowship in both the Lupus and Psoriatic Arthritis programmes with the University of Toronto at Toronto Western Hospital. The Lupus Clinic under Dr Murray B Urowitz has spanned 5 decades and has informed much of the established knowledge pertaining to SLE/lupus in that time, as well as playing key roles in the development of lupus-related outcome measures. The Psoriatic Arthritis (PsA) program set up by Dr Dafna Gladman in 1978 is equally renowned for its influence on contemporary knowledge of this disease. Both programmes are actively involved in international guideline formulation and in clinical trials of which Dr Sheane was a co-investigator in 5 separate phase III studies. During his fellowship, Dr Sheane examined a number of research topics including (in lupus) mortality, steroid use and long-term outcomes, cardiovascular disease, and (in PsA) attainment of minimal disease activity/remission with biologic treatments. Dr Sheane has contributed to a pan-Canadian initiative to establish comprehensive recommendations for the investigation and treatment of SLE.
Dr Sheane has a broad range of interests across the field of Rheumatology, including osteoarthritis and osteoporosis, with sub-specialty expertise in PsA/spondyloarthritis and SLE.
Clinical Research & Professional Memberships
Dr. Sheane is an active member of the international research organisations, GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) and OARSI (Osteoarthritis Research Society International). He is extensively published in peer-reviewed medical journals, including Annals of the Rheumatic Diseases, Journal of Clinical Rheumatology, Journal of Rheumatology and Arthritis & Rheumatology. See list of Research & Publications for further details.